Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:40 PM
Ignite Modification Date:
2025-12-24 @ 12:40 PM
NCT ID:
NCT00613561
Eligibility Criteria:
Inclusion Criteria:
* Must show one of the following diseases:
* SCIDS
* Hyper-IgM
* Wiskott-Aldrich Syndrome
* Chediak-Higashi and Griscelli Syndromes
* X-Linked Lymphoproliferative Diseases
* IPEX Syndrome
* NEMO Syndrome
* other severe immunodeficiency diseases not stated above at the discretion of the Principal Investigator
* Informed Consent
* Adequate Renal Function
* Adequate Liver Function
* Adequate Cardiac Function
* Adequate Pulmonary Function
* Adequate Performance Statue
* Adequate Venous Access
Exclusion Criteria:
* Patient/Family has not signed informed consent
* Patient does not have a clear diagnosis of a severe immunodeficiency disease
* A suitable donor for the patient cannot be found
* Patient is HIV positive
* Patient has active Hepatitis B
* Patient is pregnant
* Patient is considered unsuitable for transplant at the discretion of the Principal Investigators or the medical director
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
11 Years
Study:
NCT00613561
Study Brief:
Protocol Section:
NCT00613561